Early angiography versus conservative treatment in patients with non–ST elevation acute myocardial infarction  by Scull, Grant S et al.
Interventional Cardiology
Early Angiography Versus Conservative
Treatment in Patients With
Non–ST Elevation Acute Myocardial Infarction
Grant S. Scull, MD,* Jenny S. Martin, RN,* W. Douglas Weaver, MD, FACC,†
Nathan R. Every, MD, MPH,‡ for the MITI Investigators
Seattle, Washington; Detroit, Michigan
OBJECTIVES To compare short- and long-term outcome after early invasive or conservative strategies in the
treatment of non-ST segment elevation acute myocardial infarction (AMI).
BACKGROUND It is uncertain whether or not there is benefit from emergent invasive diagnosis and treatment
of AMI in patients without ST segment elevation on the admission electrocardiogram
(ECG).
METHODS In a cohort of 1,635 consecutive patients with AMI who presented to hospitals without ST
segment elevation on their admission ECG, we compared treatments, hospital course and
outcome in 308 patients who presented to hospitals whose initial strategy favored early
angiography and appropriate intervention when indicated versus 1,327 similar patients who
presented to hospitals that favor a more conservative initial approach.
RESULTS At baseline, patients admitted to hospitals favoring an early invasive strategy were younger,
more predominately Caucasian and had less comorbidity. Early coronary angiography
occurred in 58.8% versus 8% (p , 0.001), and early angioplasty was performed in 44.8%
versus 6.1% (p , 0.001) in the two different cohorts. Patients treated in hospitals favoring the
early invasive strategy had a lower 30-day (5.5% vs. 9.5%, p 5 0.026) and four-year mortality
(20% vs. 37%, p , 0.001). Multivariate analysis showed a trend towards lower hospital
mortality (OR 5 0.56, 95% CI: 0.29 to 1.09) and a significant lower long-term mortality
(hazard ratio 5 0.61, 95% CI: 0.47 to 0.80) in patients admitted to hospitals favoring an early
invasive strategy.
CONCLUSIONS These data suggested that an early invasive strategy in patients with AMI and nondiagnostic
ECG changes is associated with lower long-term mortality. (J Am Coll Cardiol 2000;35:
895–902) © 2000 by the American College of Cardiology
Patients who present to the hospital with symptoms con-
sistent with acute myocardial infarction (AMI) but have a
nondiagnostic electrocardiogram represent a clinical chal-
lenge. Whereas patients who present with ST segment
elevation are readily identified and can be treated with acute
reperfusion therapy, those with AMI and nondiagnostic
electrocardiograms (ECGs) are more difficult to diagnose at
the time of admission and have not been shown to benefit
from thrombolysis (1). Although hospital mortality is some-
what lower in patients who present with nondiagnostic
ECG changes than in patients with ST segment elevation,
long-term rates of reinfarction and mortality are similar (2).
Acute angiography and reperfusion by coronary angio-
plasty or bypass surgery has been shown to result in
improved outcomes in patients with AMI who present with
ST segment elevation (3). However, in the setting of AMI
without ST elevation, the value of acute intervention is less
certain (1,4–7). The Thrombolysis in Myocardial Infarction
(TIMI) IIIB trial (1,6) showed no benefit from a strategy
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of early invasive coronary angiography with target vessel
revascularization, and the recent Veterans Affairs Non-Q
Wave Infarction Strategies in Hospital (VANQWISH)
trial showed worse outcome in these patients (4). However,
Lotan et al. (5) showed improved short-term outcome in
anterior wall AMI patients without ST segment elevation
who were treated with an initial early invasive approach.
None of these studies evaluated very early (,6 h) revascu-
larization at the time of admission, and there is little data on
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outcome beyond one year. Thus, there is no consensus as to
the efficacy of an early invasive strategy in this high risk
patient group.
The Myocardial Infarction Triage and Intervention
(MITI) Registry contains detailed data on a cohort of
12,331 consecutive patients with AMI. Because there was
substantial variation in the process of care among the 19
hospitals in the registry, the initial approach to treatment of
patients was more often determined by where patients were
admitted than by characteristics of the patients themselves.
Some Seattle-area hospitals favored an early diagnostic and
intervention strategy in patients with suspected non-ST
segment elevation AMI, while other hospitals favored a
much more conservative initial strategy. We were, thus, able
to perform an observational study comparing the influence
of early invasive strategies on short- and long-term patient
outcome.
METHODS
The subjects of this study were selected from a population of
12,331 consecutive patients with AMI who were enrolled in
the MITI Registry between 1988 and 1994. Characteristics
of the Registry, data-gathering procedures and reliability
have been previously described (8). The MITI Trial and
Registry was a collaborative effort to evaluate new treatment
strategies for patients with AMI. The University of Wash-
ington Human Subjects Review Committee approved the
study.
We performed a retrospective cohort analysis. The study
cohort included 1,635 patients from the MITI Registry who
had a confirmed AMI during their index hospitalization
(based on a peak serum CPK/CPK-MB ./5 23 normal)
but showed no ST segment elevation on their admission
12-lead ECG. Patients with evidence of cardiogenic shock
at the time of admission were excluded. This cohort was
divided into two groups: those patients initially admitted to
hospitals that favored an early invasive strategy versus those
that favored an initial conservative medical strategy. Hos-
pitals favoring an early invasive strategy were defined as
those hospitals that performed cardiac catheterization
within 6 h of admission on 25% or more of patients with
chest pain and nondiagnostic ECG changes. There were
308 patients included in the early invasive group admitted to
two hospitals and 1,327 patients included in the conserva-
tive group admitted to the 17 remaining hospitals that
favored a more conservative initial strategy. Eight of the 17
hospitals favoring a conservative initial strategy had on-site
cardiac catheterization facilities.
Data collected. Trained abstractors collected detailed data
on the patients’ demographic characteristics, clinical presen-
tation, hospital course and procedures within 3 months after
discharge. Socioeconomic status (SES) was obtained by
linking the registry to U.S. census data that assigns averages
of education and income based on the address of the
Registry patient. Readmissions and the rates of subsequent
use of procedures were obtained by linking the MITI
Registry to the Washington State Comprehensive Hospital
Abstract Reporting System (CHARS). The CHARS data-
base includes vital status for every hospital admission in the
state of Washington. The rates of readmission and use of
cardiac procedures were calculated at one and three years
and are cumulative. The cardiac procedure use rate after
discharge did not include procedures performed during the
index admission.
Statistical analysis. Chi-square test, ANOVA and Stu-
dent t tests were used to test for significant differences in
baseline characteristics between patients in the early invasive
and conservative cohorts. The rates of cardiac procedure use
after discharge were compared at one and three years, and
long-term mortality was compared with Kaplan-Meier plots
and the log-rank test. To test whether there was an
association between early invasive use of coronary angiog-
raphy in suspected non-ST elevation AMI and hospital
mortality independent of baseline differences, we con-
structed a series of logistic regression models. Factors
associated with mortality in univariate comparisons were
entered into the model in a step-wise fashion with type of
admitting hospital (early invasive vs. conservative) forced
into the model in the final step. The multivariate association
between type of admitting hospital and long-term mortality
was performed in a similar fashion using Cox regression
models.
RESULTS
Baseline characteristics. Patients admitted to the hospitals
favoring an early invasive strategy were younger (64 vs. 68
years, p , 0.001), more predominately Caucasian (98% vs.
91%, p , 0.001) and had higher SES on average (owner
occupied housing 72% vs. 61%, p , 0.001, median house-
hold annual income $48,197 vs. $36,064, p , 0.001, college
graduate 42.9% vs. 34.6%, p , 0.001). They had a lower
prevalence of prior angina (37% vs. 48%, p , 0.001), past
history of MI (20% vs. 30%, p , 0.001) and congestive
heart failure (9% vs. 17%, p , 0.001). Electrocardiogram at
Abbreviations and Acronyms
ACEI 5 angiotensin converting enzyme
inhibitor
AMI 5 acute myocardial infarction
CHARS 5 Washington State Comprehensive
Hospital Abstract Reporting System
ECG 5 electrocardiogram
MITI 5 Myocardial Infarction Triage and
Intervention
SES 5 socioeconomic status
TIMI 5 Thrombolysis in Myocardial Infarction
VANQWISH 5 Veterans Affairs Non-Q Wave Infarc-
tion Strategies in Hospital
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presentation varied between cohorts; there were modest
differences in the proportion of patients presenting with ST
segment depression (36% vs. 44%, p 5 0.01 in early invasive
and conservative hospitals, respectively), T wave inversion
(25% vs. 27%, p 5 0.51) or “other” ECG findings (31% vs.
37%, p 5 0.09). There were no significant differences in
gender, past history of hypertension, cardiac surgery, diabe-
tes or cigarette smoking (Table 1). There was no difference
in mean peak CPK values between the two groups (1,133 6
1,506 vs. 1,042 6 1,069, p 5 0.36).
Hospital procedure use and short-term outcome. As
expected, patients admitted to hospitals favoring an early
invasive strategy were more likely to undergo cardiac cath-
eterization during their index hospitalization than patients
admitted to hospitals favoring a conservative initial strategy
(86% vs. 52%, p , 0.001). Patients admitted to hospitals
favoring an early invasive strategy were also more likely to
undergo cardiac catheterization within 6 h of presenting to
the emergency department (59% vs. 8%, p , 0.001). They
were also more likely to undergo angioplasty during their
index hospitalization (60% vs. 22%, p , 0.001) and within
6 h of admission (45% vs. 6%, p , 0.001). Coronary artery
bypass graft surgery was performed more often in patients
admitted to early invasive hospitals (20% vs. 13%, p 5
0.001) (Fig. 1). The types of cardiac medications prescribed
at discharge were similar between the two cohorts. How-
ever, patients at hospitals favoring an early invasive strategy
were more likely to be discharged with aspirin (71% vs. 63%,
p 5 0.018) and less likely to be discharged with beta-
adrenergic blocking agents (17% vs. 27%, p , 0.001). There
was no gender difference for patients who underwent
coronary angiography during hospitalization between the
early invasive and conservative cohorts (73% vs. 74% male
gender, p 5 0.789). There was also no difference in the
proportion of men undergoing angiography within 6 h of
admission between the two cohorts (75% vs. 82%, p 5
0.11).
Patients admitted to hospitals favoring an early invasive
strategy were less likely to develop evidence of new conges-
tive heart failure during their index hospitalization than
patients admitted to hospitals favoring a conservative initial
strategy (24% vs. 35%, p 5 0.001). There was no significant
difference in the rate of stroke between the two groups.
Unadjusted 30-day mortality was lower in patients admitted
to hospitals favoring an early invasive strategy (5.5% vs.
9.5%, p 5 0.026), and there was a trend in this group
toward decreased recurrent AMI (2.3% vs. 3.5%, p 5 0.287)
(Fig. 2). In order to evaluate the association between the
type of admitting hospital (early invasive vs. conservative)
and hospital mortality independent of differences in baseline
characteristics, we performed a series of logistic regression
models. Factors associated with higher hospital mortality
included increased age, in-hospital extension of MI, in-
hospital stroke and new-onset heart failure. There was a
nonsignificant association between admission to an early
invasive hospital and lower mortality (OR 5 0.56, 95% CI:
0.25 to 1.21) (Fig. 3).
To further examine the outcome effect of early invasive
angiography, we performed a subgroup analysis of only
those patients admitted to hospitals favoring an early
Table 1. Baseline Characteristics of Patients With AMI and Nondiagnostic ECG Changes
Admitted to Conservative Hospitals Versus Hospitals Favoring an Early Invasive Strategy*
Conservative
(n 5 1,327)
Early Invasive
(n 5 412) p Value
Age, yr (mean 6 standard deviation) 68 6 12.7 64 6 12.2 , 0.001
Gender (% male) 66 70 0.149
Race (% white) 91 98 , 0.001
SES
Owner-occupied housing 61 72 , 0.001
Median household income $36,064 $48,197 , 0.001
College graduate 34 42 , 0.001
Professional, executive, manager 20 26 , 0.001
Prior history
Angina 48 36 , 0.001
Hypertension 50 51 0.726
Myocardial infarction 30 20 , 0.001
Congestive heart failure 17 9 , 0.001
Cardiac surgery 12 15 0.257
Diabetes 21 16 0.093
Smoking cigarettes 32 27 0.082
ECG findings
ST segment depression 44.3% 36.2% 0.012
T wave inversion 25.0% 26.9% 0.510
Other ECG findings 30.7% 36.9% 0.091
*Conservative and early invasive hospitals as defined in “Methods” section.
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invasive strategy. We compared in-hospital mortality of
patients who received coronary angiography within 6 h of
admission to those who did not. We found that patients
who received early invasive coronary angiography had sig-
nificantly lower in-hospital mortality than those who did
not (1.1% vs. 7.1%, p 5 0.005). After adjustment for
differences in patients who did versus those who did not
receive early angiography, there was a nonsignificant trend
between early angiography and lower hospital mortality
(OR 5 0.29 95%, CI 5 0.06 to 1.4).
Long-term outcome. Patients were followed for a mean of
3.2 years. After hospital discharge, patients admitted to
hospitals favoring an early invasive strategy were more likely
to undergo subsequent cardiac catheterization (23% vs. 16%,
p 5 0.012 at three years) (Fig. 4). There were no differences
between the groups in the rate of cardiac-related rehospi-
talizations, coronary angioplasty or bypass surgery at one
and three year follow-up.
Patients admitted to hospitals favoring an early invasive
strategy had better long-term survival than those admitted
Figure 1. In-hospital procedures performed at conservative hospitals versus hospitals favoring an early invasive strategy. Patients admitted
to hospitals favoring an early invasive strategy were more likely to undergo coronary angiography, coronary angioplasty and coronary artery
bypass grafting during their index hospitalization, as well as coronary angiography and coronary angioplasty within 6 h of admission and
coronary artery bypass grafting within 24 h of admission. *p , 0.05. Closed bar 5 conservative; open bar 5 early invasive.
Figure 2. Hospital events at conservative hospitals versus hospitals favoring an early invasive strategy. More patients admitted to hospitals
favoring a conservative initial strategy developed congestive heart failure during their index hospitalization. Additionally, 30-day mortality
was higher at hospitals favoring a conservative initial strategy. MI 5 myocardial infarction; 30 day death 5 death within 30 days of index
admission. *p , 0.05. Closed bar 5 conservative; open bar 5 early invasive.
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to hospitals favoring a conservative initial strategy (81% vs.
63% at four years, p , 0.001) (Fig. 5). This survival
advantage was greatest in a subpopulation of patients
presenting with ST depression (75% vs. 53% at four years,
p , 0.001).
To investigate the association between type of admitting
hospital (early invasive vs. conservative) and long-term
mortality independent of differences in the baseline charac-
teristics of cohorts, we performed multivariate Cox analyses.
Factors associated with increased long-term mortality in-
cluded older age, employment in a “blue collar” occupation,
heart failure during the hospitalization, stroke, prior heart
failure and prior myocardial infarction (Fig. 6). Factors
associated with lower long-term mortality included dis-
charge medications of either ASA or beta-blockers. After
adjustment for these factors, there was a significant associ-
ation between admission to hospitals favoring an early
invasive strategy and lower long-term mortality (hazard
ratio 5 0.63, 95% CI: 0.47 to 0.83).
We further validated our results by evaluating a subgroup
of 708 patients less than or equal to 65 years of age (173
admitted to early invasive hospitals and 535 admitted to
more conservative hospitals). This subgroup was better
matched in terms of age (55.2 6 6.7 vs. 54.9 6 7.6 years,
Figure 3. Factors associated with a higher risk of death during the index hospitalization in patients admitted to early invasive and hospitals
favoring a conservative initial strategy. Odds ratios to the right of the line of identity (odds ratio, 1) are associated with a higher risk of
in-hospital mortality. After adjustment for all measured factors that predict mortality, there was a nonsignificant association between
admission to hospitals favoring an early invasive strategy and reduced in-hospital mortality (OR 5 0.56, 95% CI, 0.29 to 1.093).
Figure 4. Procedures after discharge at conservative hospitals versus hospitals favoring an early invasive strategy. Patients treated at
hospitals favoring an early invasive strategy were more likely to undergo repeat coronary angiography by one and three years. There was
no difference in the rate of coronary angioplasty or coronary artery bypass grafting by one or three years. *p , 0.05. Closed bar 5
conservative; open bar 5 early invasive.
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p 5 0.64 in early invasive vs. conservative patients, respec-
tively) and gender (17.9% vs. 22.1% female, p 5 0.146).
Past history was similar except for a lower proportion of past
heart failure in patients admitted to early invasive hospitals
(4.0% vs. 8.6%, p 5 0.05). Mortality at hospital discharge
and at four years follow-up was lower in patients admitted
to early invasive hospitals (0% vs. 3.2%, p 5 0.008 at
hospital discharge and 12.9% vs. 19.7%, p 5 0.078 at four
years follow-up). After multivariate adjustment for differ-
ences in baseline characteristics in this subgroup of patients,
there was a nonsignificant association between admission to
an early invasive hospital and lower long-term mortality
(hazard ratio 5 0.65, 95% CI 5 0.38 to 1.13).
DISCUSSION
One of the reasons for the declining mortality rate in
patients with AMI is the rapid diagnosis and treatment of
patients presenting with ST segment elevation (9). For
patients without ST segment elevation on their admission
12-lead ECG, evidence for rapid identification and treat-
ment has been less convincing (3–6). The use of thrombo-
Figure 5. Survival rates during follow-up in patients admitted to early invasive and hospitals favoring a conservative initial strategy. In this
unadjusted comparison, patients treated at hospitals favoring an early invasive strategy had improved long-term survival (81% vs. 63% at
four years, p , 0.001, mean follow-up 3.2 years). Closed square 5 conservative; open square 5 early invasive.
Figure 6. Factors associated with higher risk of death during follow-up in patients admitted to early invasive and hospitals favoring a
conservative initial strategy. Hazard ratios to the right of the line of identity (hazard ratio, 1) are associated with a higher risk of long-term
mortality. After adjustment for all measured factors that predict mortality, admission to hospitals favoring an early invasive strategy was
independently associated with decreased long-term mortality (hazard ratio 0.61, 95% CI, 0.47 to 0.80).
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lytic therapy in this patient group has resulted in less
favorable outcomes (1). Several therapies, such as the use of
aspirin (10), beta-blockers (11) and angiotensin converting
enzyme inhibitors (ACEI) (12) have been shown to reduce
mortality in patients with AMI and non–ST segment
elevation on the admission ECG. However, no therapies
have been identified in this patient group that, when
delivered early, could lead to attenuation of myocardial cell
death.
The early use of coronary angiography and revasculariza-
tion, if needed, holds theoretical promise for identification
and treatment of high-risk infarct patients. We evaluated
data from the MITI Registry in 1,635 AMI patients to see
if admission to hospitals that favor early angiography and
revascularization in these patients was associated with im-
proved short-term or long-term outcomes.
Findings. In this observational study, we found that pa-
tients admitted to hospitals favoring an early invasive
strategy were far more likely to undergo cardiac procedures
both emergently (,6 h) and electively. This treatment
strategy was associated with lower rates of heart failure
during the index hospitalization and lower 30-day mortality.
Indeed, after a mean of 3.2 years of follow-up, patients
admitted to hospitals favoring an early invasive strategy had
lower mortality in comparison with those admitted to
hospitals favoring a conservative initial strategy. Multivari-
ate analysis showed that admission to hospitals favoring an
early invasive strategy was an independent predictor of
decreased long-term mortality. This observed lower mortal-
ity in the early invasive cohort may have been a function of
either earlier revascularization and associated improved
myocardial salvage or simply more revascularization than
those patients admitted to hospitals favoring a conservative
initial strategy. However, the remarkably low mortality
observed in our subgroup analysis of patients admitted to
hospitals favoring an early invasive strategy who actually
underwent angiography within 6 h of admission (1.1% vs.
7.1%, p 5 0.005 in hospital, 10% vs. 32.5%, p , 0.001 at
four years post-index event) argues that myocardial salvage
may play an important role.
Previous studies. These findings differ from previous stud-
ies evaluating early invasive therapy in non-ST elevation
AMI patients. In the TIMI IIIB randomized trial (1), there
was no mortality benefit in patients with non-Q wave AMI
or unstable angina randomized to an early invasive strategy
(arteriography with revascularization if indicated). In this
trial, early invasive angiography was designed to be per-
formed 18 to 48 h after randomization, and patients
randomized to early invasive therapy were treated relatively
late after hospital admission (mean 36 h). After such a delay,
there may be less myocardial salvage and, therefore, less
benefit from revascularization. In addition, the TIMI IIIB
study consisted predominately of patients with unstable
angina in whom the risk of death is less than for AMI.
More recently, the results of the VANQWISH trial were
reported (4). In this trial, patients with non–Q Wave AMI
were randomized to either catheterization and revascular-
ization (invasive strategy) or a more conservative approach,
with catheterization and revascularization reserved only for
patients with either rest or inducible ischemia before dis-
charge. In this trial, patients randomized to the invasive
strategy had higher mortality and more cardiac events than
the conservative strategy in-hospital and up to 12 months
after randomization but showed no significant difference in
outcome at 23 months. The VANQWISH trial differed
from the MITI study in that catheterizations in the
VANQWISH trial were performed electively after admis-
sion, with a mean time from randomization to revascular-
ization of eight days in the invasive strategy group. This
delay in revascularization could account for the difference in
results between VANQWISH and our study. Early angiog-
raphy was performed earlier in the Medicine Versus An-
giography in Thrombolytic Exclusion trial (mean time
27 h); however, there still was no observed difference in
outcome in patients randomized to a strategy of early
catheterization and intervention (7).
In contrast to those trials, the recently reported Fast
Revascularization during Instability in Coronary Disease
study (FRISC II) showed a 21% reduction in death or MI
in patients randomized to early angiography (2 to 7 days)
versus a more conservative ischemia-driven strategy (13).
Lotan et al. (5) also observed improved outcomes with an
early invasive strategy in a study of 110 patients with non-Q
wave AMI. In this study, patients with non–Q wave
anterior wall AMIs were retrospectively evaluated by
whether or not they received early invasive therapy. Lotan
found that patients treated with an early invasive strategy
had fewer recurrent AMIs, decreased angina pectoris, less
congestive heart failure and improved long-term survival at
three years. The patients in Lotan’s study were assigned to
cohorts based on treatment, unlike our study in which
patients were assigned to cohorts based on their admission
hospitals.
Implications. Taken together, these studies imply that
there may be a benefit of early catheterization without prior
noninvasive testing in select patients after non-ST segment
elevation MI. The conflicting results are more likely a result
of patient selection and choice of revascularization protocols
in the trials. What is less clear is the value of early
catheterization (within 6 h of admission) as was evaluated in
the present MITI Registry study. Although we found an
association between early catheterization and improved
outcome, our findings should be confirmed in a randomized
trial.
Study limitations. Although our findings are provocative,
there are limitations inherent in a retrospective cohort
analysis. Because neither the admitting hospital nor treat-
ments received were randomly assigned, there could be
selection bias in our analyses. We attempted to control bias
by performing analyses based on the admitting hospital
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rather than by the treatments a patient had received. This
resulted in some balance between cohorts. However, pa-
tients admitted to hospitals favoring an early invasive
strategy were, in fact, younger, had higher SES and had less
comorbidity. Although we could adjust for these measured
factors by performing multivariate analyses, we could not
adjust for unmeasured differences between cohorts. Unlike
many other registry studies, however, in the MITI Registry,
we were able to account for patient transfer, measure and
adjust for differences in SES and obtain accurate long-term
follow-up. These advantages minimize, but do not elimi-
nate, the selection bias inherent in observational studies.
Conclusions. We conclude that admission to a hospital
that favors a strategy of early coronary angiography and
revascularization is associated with lower long-term mortal-
ity in select patients presenting with nonspecific findings on
admission ECG. Our data support performing a random-
ized trial to evaluate an early invasive strategy in the
treatment of patients who present with symptoms of AMI
but without ST segment elevation on their admission ECG.
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